There are a number of oil and gas basins in the United States, but the one that E&P operators keep coming back to is the Permian. Other basins have their own geologic, operational, and financial advantages, but the Permian has…
Financial Services organizations face increasing pressure to improve their Anti-Money Laundering (AML) compliance programs—and there’s a lot at stake. Among other things, AML programs, which are defined by regulations and mandated by law: Stop illicit use of global financial networks.…
“Within the next year, the number of data and analytics experts in business units will grow at three times the rate of experts in IT departments, which will force companies to rethink their organizational models and skill sets.” – Gartner,…
With the intention of making data more FAIR (Findable, Accessible, Interoperable, Re-usable), organizations have invested a lot of time and money on software to identify and track datasets across existing data sources in the organization. Many software solutions promise a…
In my last post, I covered how Tamr’s software can be applied to many areas of the oil and gas industry to master information and find hidden value in messy data sets. One of the examples from that article centered…
Every quarter since 1964, the U.S. House of Representatives publishes the Statement of Disbursements (SOD), a public report of all their receipts and expenditures. The available datasets span almost 10 years, from Q1 2010 to Q2 2019, and includes 21…
My previous post focused on the urgent Know-Your-Customer (KYC) and Anti-Money-Laundering (AML) issues facing financial institutions and the specific needs of business units. Business units are under pressure to keep pace, but so are compliance and auditing. All three lines…
The FAIR data principles are finally emerging from the halls of academia to find their place in the commercial world. And not a moment too soon for life sciences businesses, as they begin to treat their R&D data as first-class…
The digital transformation towards more agile, data-driven operations for clinical studies have been a critical part of every life science company’s roadmap as they build towards reducing the time and costs of drug development in order to get medical products…
A few years ago, when Panama Papers and other offshore leaks were the subject of news stories, I remember reading an article about a woman, a resident of a small island in the Caribbean, who was listed as a director…
